SCHEMBL24309647

SCHEMBL24309647

Cc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2ccccc2Cl)c1C(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MAP3K7 O43318 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ MAP2K1 Q02750 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310590 0.93 IGF1R (0.31) —
SCHEMBL24309551 0.88 FYN (0.32) —
SCHEMBL24310217 0.88 HTR1A (0.31) —
SCHEMBL24309576 0.86 JAK2 (0.33) —
SCHEMBL24310558 0.85 IGF1R (0.31) —
SCHEMBL24309901 0.84 IGF1R (0.33) MAP3K7MAPK1MAP2K1
SCHEMBL24310085 0.83 CDK1 (0.30) —
SCHEMBL24309830 0.82 IGF1R (0.32) MAP3K7MAPK1MAP2K1
SCHEMBL29566687 0.82 HTR1A (0.39) MAP3K7MAPK1MAP2K1
SCHEMBL24310179 0.81 IGF1R (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback